Connect
← Return to Biochemical Relapse After Lu-177 PSMA — Options for Bone-only mCRPC
Discussion
Biochemical Relapse After Lu-177 PSMA — Options for Bone-only mCRPC
Prostate Cancer | Last Active: May 10 8:52pm | Replies (24)Comment receiving replies
@jeffmarc, do you know of people with metastatic PCA in the 80 plus age group who opted for low dose Docetaxel after exhausting all other options (including Pluvicto), and did reasonably well after that (in terms of quality of life, survival etc)? Basically, want to know if the benefit of low dose chemo at this stage outweighs it's toxicity risks.
Replies to "@jeffmarc, do you know of people with metastatic PCA in the 80 plus age group who..."
Connect
@sumith
I know a lot of guys over at ancan.org That are on Nubeqa Alone. Many of them in there are in their 80s or late 70s. I am not sure if any of them are taking the lower dose of it. I have heard one person talk about it, You could attend one of the meetings and ask about it. Just signing up for the advanced prostate cancer meetings gets you a newsletter every week that has a whole bunch of information on new things going on in treatment.
I also attend CSC meetings and one guy moved to South Africa and is now on just Nubeqa And it’s working great for him. He has a very extensive case with a Gleason nine And he had a lot of metastasis to start.